EDGAR Filing Documents for 0000893220-07-000711

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0000893220-07-000711

Filing Date

2007-03-13

Accepted

2007-03-13 15:44:36

Documents

Period of Report

2005-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K/A PAR PHARMACEUTICAL COMPANIES, INC.	w29850e10vkza.htm	10-K/A	1386870
2	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	w29850exv31w1.htm	EX-31.1	8684
3	CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER	w29850exv31w2.htm	EX-31.2	8496
4	CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350	w29850exv32w1.htm	EX-32.1	3623
5	CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350	w29850exv32w2.htm	EX-32.2	3656
	Complete submission text file	0000893220-07-000711.txt		1412843

Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677

Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100

PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)